Effect of Khadira suppository and clingen forte vaginal capsules in the management of vulvovaginitis during pregnancy

Effect of Khadira suppository in the management of Upapluta Yoni Vyapath vis-a-vis vulvovaginitis in pregnancy-An open label standard controlled clinical study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085360

Enrollment

Registered

2025-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N760- Acute vaginitis Health Condition 2: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pregnant women between the age group of 19 to 35 years, subjects having clinical features such as vaginal discharge, vulvar itching, burning sensation in vagina, pain in vagina, foul smell in vagina. 2.Pregnant women with irrespective of parity between 8 to 28 weeks of gestation 3.On pelvic examination inflammation Of vulva and vagina.

Exclusion criteria

Exclusion criteria: 1.Pregnant women with known case of medical disease such as Diabetes mellitus, hypertension, thyroid abnormalities, any organic pathology or hepatic, cardiac, renal disease or any acute infection. 2.Known case of Obstetric complications such as placenta Previa, cervical insufficiency and twin pregnancy. 3. History of previous abortion and known case of threatened abortion. 4. History of sexually transmitted diseases and known case of Human Immunodeficiency Virus. 5. Known case of congenital vaginal anomalies.

Design outcomes

Primary

Measure	Time frame
The effect of Khadira suppository in upapluta Yoni Vyapad. The effect of clingen forte vaginal capsule in vulvovaginitis during pregnancy The efficacy of Khadira suppository versus clingen forte vaginal capsule in vulvovaginitis during pregnancyTimepoint: 1 week	—

Secondary

Measure	Time frame
To determine the disintegration time of trial suppository.Timepoint: 1 hour	—

Countries

India

Contacts

Public ContactDr Usha D T

JSS Ayurveda Medical college and Hospital, Mysuru

Usha.ayurveda@gmail.com9164455019

Outcome results